InflaRx N.V. Stock Price (IFRX)

Key Statistics

Open
Previous Close
Bid
Ask
Day Range -
52 Week Range -
Volume
Avg. Volume
Volume to USD
Market Cap
Beta
PE Ratio
Latest EPS
EPS TTM
Dividend
Dividend Yield
Ex-Dividend Date
Revenue TTM
Revenue per Share
Revenue per Employee
Profit Margin
Gross Profit TTM
Total Cash TTM
Total Debt TTM

Share Distribution

Shares Outstanding
Float
Short Interest
Short Ratio
Insider Ownership
Institution Ownership

Latest Headlines

Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q4 2021 Results - Earnings Call TranscriptSat, 8 May 2021 00:22:06 UTC via Seeking Alpha
Prestige Consumer Healthcare Inc. 2021 Q4 - Results - Earnings Call PresentationFri, 7 May 2021 22:56:54 UTC via Seeking Alpha
Diversified Healthcare Trust (DHC) Management on Q1 2021 Results - Earnings Call TranscriptFri, 7 May 2021 20:42:02 UTC via Seeking Alpha
Community Healthcare Trust, Inc. (CHCT) CEO Tim Wallace on Q1 2021 Results - Earnings Call TranscriptFri, 7 May 2021 11:49:07 UTC via Seeking Alpha
HCA Is A Unique Healthcare PlayThu, 6 May 2021 16:50:08 UTC via Seeking Alpha
Tenet Healthcare stock price target raised to $70 from $55 at MizuhoWed, 5 May 2021 06:45:40 UTC via MarketWatch
Omega Healthcare Investors, Inc. (OHI) CEO Taylor Pickett on Q1 2021 Results - Earnings Call TranscriptTue, 4 May 2021 16:01:04 UTC via Seeking Alpha
Disrupting Healthcare - IPO Interview With Privia Health CEO Shawn Morris (Video)Mon, 3 May 2021 15:35:48 UTC via Seeking Alpha
Tenet Healthcare Corp (THC): Price Now Near $60.97; Daily Chart Shows An Uptrend on 20 Day BasisMon, 3 May 2021 11:08:35 UTC via ETF Daily News
Aveanna Healthcare - Home Care PlaySun, 2 May 2021 01:47:12 UTC via Seeking Alpha

InflaRx N.V. Performance

5 Day Change 1 Month Change 30 Day Change 3 Month Change 90 Day Change 6 Month Change 180 Day Change Year to Date Change 1 Year Change 2 Year Change 5 Year Change

Active Alerts for IEX:IFRX

You don't have any alerts set for IEX:IFRX.

About InflaRx N.V.

InflaRx NV is a biopharmaceutical company. It discovers and develops potent and specific inhibitors of the complement activation factor known as C5a.

CEONiels Riedemann IndustryBiotechnology SectorHealthcare Websitehttp://www.inflarx.com Issue ExchangeNasdaq Global Select Issue TypeUnknown

Real-time IFRX to USD Trade Analysis on IEX

Market Status Closed

Analysis is available when the exchange & market are open.